Updates are available Correction dated 2019-03-21
Click to view Correction: https://doi.org/10.1038/s41587-019-0108-0
-
Authors
,
Krusche, Peter
Trigg, Len
Boutros, Paul C. https://orcid.org/0000-0003-0553-7520
Mason, Christopher E. https://orcid.org/0000-0002-1850-1642
De La Vega, Francisco M. https://orcid.org/0000-0002-9228-2097
Moore, Benjamin L. https://orcid.org/0000-0002-4074-1933
Gonzalez-Porta, Mar
Eberle, Michael A.
Tezak, Zivana
Lababidi, Samir
Truty, Rebecca
Asimenos, George
Funke, Birgit
Fleharty, Mark
Chapman, Brad A.
Salit, Marc
Zook, Justin M. https://orcid.org/0000-0003-2309-8402
- License Information
-
More Information
Article History
Received: 23 May 2018
Accepted: 10 January 2019
First Online: 11 March 2019
Change Date: 21 March 2019
Change Type: Correction
Change Details: In the version of this article initially published online, two pairs of headings were switched with each other in Table 4: “Recall (PCR free)” was switched with “Recall (with PCR),” and “Precision (PCR free)” was switched with “Precision (with PCR).” The error has been corrected in the print, PDF and HTML versions of this article.
Competing interests
: P.K., B.L.M., M.G., and M.A.E. are employees of, and/or hold stock in, Illumina. R.T. is an employee of, and holds stock in, Invitae. G.A. is an employee of DNAnexus. B.F. is an employee of Veritas Genetics and holds leadership positions in AMP, CLSI, CAP, and ClinGen. L.T. is an employee of Real Time Genomics. C.E.M. is a founder of Onegevity Health and Biotia, Inc.
